Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 64, Issue 2, 1996, Pages 193-200

  Rieckmann, Peter ^a,c   Weber, Frank ^a   Günther, Astrid ^a   Martin, Stephan ^b   Bitsch, Andreas ^a   Broocks, Andreas ^a   Kitze, Bernd ^a   Weber, Thomas ^a   Börner, Thomas ^a   Poser, Sigrid ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cytokines; Multiple sclerosis; Pentoxifylline; Treatment; Tumor necrosis factor

Indexed keywords

ANTIGEN CD54; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

EID: 0029993357     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(95)00176-X     Document Type: Article

References (44)

1. Baron, J.L., Madri, J.A, Ruddle, N.H., Hashim, G. and Janeway, C.A. (1993) Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177, 57-68.
2. Beck, J., Rondot, P., Catinot, L., Falcoff, E., Kirchner, H. and Wietzerbin, J. (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78, 318-323.
3. 1b effects on cytokine mRNA in multiple sclerosis. (Abstract T218 presented at the 120th Annual Meeting of the American Neurological Association).
4. Chao, C.C., Hu, S., Gekker, G., Novick, W.J., Remington, J.S. and Peterson, P.K. (1993) Effects of cytokine on multiplication of Toxoplasma gondii in microglial cells. J. Immunol. 151, 328-334.
5. Chofflon, M., Juillard, C., Juillard, P., Gauthier, G. and Grau, G.E. (1992) Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Netw. 3, 523-531.
6. Compston, A. (1993) Inflammation and the brain. Mol. Chem. Neuropathol. 19, 47-64.
7. Cross, H. (1992) Immune cell traffic control and the central nervous system. Semin. Neurosci. 4, 213-219.
8. Genain, C.P., Roberts, T., Davis, R.L., Nguyen, M.H., Uccelli, A., Faulds, D., Li, Y., Hedgpeth, J. and Hauser, S. (1995) Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA 92, 3601-3605.
9. Giroir, B.P. and Beutler, B. (1992) Effect of amrinone on tumor necrosis factor production in endotoxic shock. Circ. Shock 36, 200-207.
10. Han, J., Huez, G. and Beutler, B. (1991) Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J. Immunol. 146, 1843-1848.
11. Hartung, H.P. (1993) Immune-mediated demyelination. Ann. Neurol. 33, 563-567.
12. Hickey, W.F., Hsu, B.L. and Kimura, H. (1991) T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254-260.
13. Hofman, F.M., Hinton, D.R., Johnson, K. and Merrill, J.E. (1989) Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607-612.
14. Lechner, A.J., Rouben, L.R., Potthoff, L.H., Tredway, T.L. and Matuschak, G.M. (1993) Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Circ. Shock 39, 306-315.
15. Leonard, J.P., Waldburger, K.E. and Goldman, S.J. (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181, 381-386.
16. Martin, R., McFarland, H.F. and McFarlin, D.E. (1992) Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153-187.
17. McCarron, R.M., Wang, L., Racke, M.K., McFarlin, D.E. and Spatz, M. (1993) Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43, 23-30.
18. Merrill, J. (1992) Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunother. 12, 167-172.
19. Nataf, S., Louboutin, J.P., Chabannes, D., Feve, J.R. and Muller, J.Y. (1993) Pentoxifylline inhibits experimental allergic encephalomyelitis. Acta Neurol. Scand. 88, 97-99.
20. Olsson, T. (1992) Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J. Neuroimmunol. 40, 211-218.
21. Olsson, T. (1994) Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur. J. Neurol. 1, 7-19.
22. Orange, J.S., Salazar-Mather, T.P., Opal, S.M., Spencer, R.L., Miller, A.H., McEwen, B.S. and Biron, C.A. (1995) Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181, 901-914.
23. Paty, D.W., Li, D.K.B., Group UMS and Group I-bMSS (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 662-667.
24. Paul, W.E. and Seder, R.A. (1994) Lymphocyte responses and cytokines. Cell 76, 241-251.
25. Phipps, R.P., Stein, S.H. and Roper, R.L. (1991) A new view of prostaglandin E regulation of the immune response. Immunol. Today 12, 349-352.
26. Powell, M.B., Mitchell, D., Lederman, J., Buckmeier, J., Zamvil, S.S., Graham, M., Ruddle, N.H. and Steinman, L. (1990) Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2, 539-544.
27. Powrie, F. and Coffman, R.L. (1993) Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 14, 270-274.
28. Racke, M.K., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevach, E.M. and Röcken, M. (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180, 1961-1966.
29. Raine, C.S. (1994) Multiple sclerosis: immune system molecule expression in the central nervous system. J. Neuropathol. Exp. Neurol. 53, 328-337.
30. Raine, C.S. (1995) Multiple sclerosis: TNF revisited, with promise. Nature Med. 1, 211-214.
31. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W. and Poser, S. (1994) Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44, 1523-1526.
32. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., Helwig, A. and Poser, S. (1995a) Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37, 82-88.
33. Rieckmann, P., Albrecht, M., Ehrenreich, H., Weber, T. and Michel, U. (1995b) Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. Res. Exp. Med. 195, 17-29.
34. Rott, O., Cash, E. and Fleischer, B. (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol. 23, 1745-1751.
35. Selmaj, K.W. and Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
36. Selmaj, K., Raine, C.S., Cannella, B. and Brosnan, CF. (1991a) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
37. Selmaj, K., Raine, C.S., Farooq, M., Norton, W.T. and Brosnan, C.F. (1991b) Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147, 1522-1529.
38. Semmler, J., Wachtel, H. and Endres, S. (1993) The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells. Int. J. Immunopharmacol. 15, 409-413.
39. Sommer, N., Löschmann, P.A., Northoff, G.H., Weller, M., Steinbrecher, A., Steinbach, J.P., Lichtenfels, R., Meyermann, R., Riethmüller, A., Fontana, A., Dichgans, J. and Martin, R. (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1, 244-248.
40. Tilg, H., Eibl, B., Pichl, M., Gachter, A., Herold, M., Brankova, J., Huber, C. and Niederwieser, D. (1993) Immune response modulation by pentoxifylline in vitro. Transplantation 56, 196-201.
41. Van der Pouw Kraan, T.C.T.M., Boeije, L.C.M., Smeenk, R.J.T., Wijdenes, J. and Aarden, L.A. (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181, 775-779.
42. Ward, A. and Clissold, S.P. (1987) Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34, 50-97.
43. Weber, F., Meinl, E., Drexler, K., Czlonkowska, A., Huber, S., Fickenscher, H., Müller-Fleckenstein, I., Fleckenstein, B., Wekerle, H. and Hohlfeld, R. (1993) Transformation of human T cell clones by herpesviruis saimiri: intact antigen recognition by autonomously growing myelin basic protein-specific T cells. Proc. Natl. Acad. Sci. USA 90, 11049-11053.
44. Zabel, P., Schade, F.U. and Schlaak, M. (1993) Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 187, 447-463.